Vanda Pharmaceuticals
VNDA
VNDA
172 hedge funds and large institutions have $611M invested in Vanda Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 187 → 172 (-15)
44% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 25
Holders
172
Holding in Top 10
–
Calls
$901K
Puts
$263K
Top Buyers
| 1 | +$13M | |
| 2 | +$10.4M | |
| 3 | +$4.66M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.54M |
| 5 |
Millennium Management
New York
|
+$3.88M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$7.22M | |
| 3 | -$3.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$3.79M |
| 5 |
JPMorgan Chase & Co
New York
|
-$2.82M |